ClearPoint Neuro, Inc. (NASDAQ: CLPT) reported Q3 EPS of ($0.18), $0.01 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $8.12 million versus the consensus estimate of $7.78 million.

For earnings history and earnings-related data on ClearPoint Neuro, Inc. (CLPT) click here.